Fusidic acid resistance rates and prevalence of resistance mechanisms among Staphylococcus spp. isolated in North America and Australia, 2007-2008.
about
Coagulase-negative staphylococci.Fusidic acid resistance determinants in Staphylococcus aureus clinical isolatesInvestigational antimicrobial agents of 2013.Safety and immunogenicity of a novel Staphylococcus aureus vaccine: results from the first study of the vaccine dose range in humansEmergent and evolving antimicrobial resistance cassettes in community-associated fusidic acid and meticillin-resistant Staphylococcus aureus.Dissemination of fusidic acid resistance among Staphylococcus aureus clinical isolatesSkin Commensal Staphylococci May Act as Reservoir for Fusidic Acid Resistance GenesCurrent and Emerging Topical Antibacterials and Antiseptics: Agents, Action, and Resistance Patterns.Determination of antimicrobial resistance profile and inducible clindamycin resistance of coagulase negative staphylococci in pediatric patients: the first report from Iran.Fusidic acid resistance in Staphylococcus aureus nasal carriage strains in nine European countries.Activity of short lipopeptides and conventional antimicrobials against planktonic cells and biofilms formed by clinical strains of Staphylococcus aureus.Antimicrobial resistance of Staphylococcus aureus isolated from skin infections and its implications in various clinical conditions in Korea.Susceptibility in vitro of canine methicillin-resistant and -susceptible staphylococcal isolates to fusidic acid, chlorhexidine and miconazole: opportunities for topical therapy of canine superficial pyoderma.Dissemination of macrolides, fusidic acid and mupirocin resistance among Staphylococcus aureus clinical isolates.A central interdomain protein joint in elongation factor G regulates antibiotic sensitivity, GTP hydrolysis, and ribosome translocation.Mutagenesis mapping of the protein-protein interaction underlying FusB-type fusidic acid resistance.Activity of Fusidic Acid Tested against Staphylococci Isolated from Patients in U.S. Medical Centers in 2014.In vitro activity of CEM-102 (fusidic acid) against prevalent clones and resistant phenotypes of Staphylococcus aureus.In vitro activity of fusidic acid (CEM-102, sodium fusidate) against Staphylococcus aureus isolates from cystic fibrosis patients and its effect on the activities of tobramycin and amikacin against Pseudomonas aeruginosa and Burkholderia cepaciaA target-protection mechanism of antibiotic resistance at atomic resolution: insights into FusB-type fusidic acid resistance.Decolonization of Staphylococcus aureus in patients with atopic dermatitis: a reason for increasing resistance to antibiotics?Characterization of resistance to selected antibiotics and Panton-Valentine leukocidin-positive Staphylococcus aureus in a healthy student population at a Malaysian University.Staphylococcus aureusand topical fusidic acid use: results of a clinical audit on antimicrobial resistance
P2860
Q30401758-066B8997-6107-4DDC-8F6B-8A333F90D9ACQ34309581-E0E13420-8087-4461-8BB6-0CF6E75A8017Q34375204-985F5977-81F4-4927-B36D-98ABDC067665Q34431997-4FAB7A90-4ACD-437C-8557-F06C71D23EABQ35558082-B8173812-AFB3-474F-9936-AEF038352BDFQ35805515-9DE72538-7641-49E5-8644-8E0C1B781750Q35845423-BFC534AC-5347-428A-B61D-75E9053E1C77Q38673550-D1D34F38-FC5C-4337-B63A-32937327F130Q38862279-7E78F6C1-E3EC-4FC6-AF0E-B557A7963E3AQ39156366-93CF1718-9E3F-4D4C-942A-A2AAB5C14580Q39564554-3A5F25B2-4826-4088-9C33-3F2DA942860AQ39985562-4DB674D1-1B38-4232-9C1F-DC108A8127EAQ41444416-D2DCDC36-9C7D-4E2D-A01C-F121E6B4A547Q41708953-A6FA4D53-1BE7-4BEF-83D7-5516CE816CA9Q41833328-C00EB903-A462-47AE-A150-321A65EA5A8FQ42070250-AE044DF0-9B82-4D32-9C18-DCF9FBB020BBQ42071192-F9200F36-CDA5-4928-8AE2-5C68270B89E5Q42139264-C4D5ACEA-97FB-4ACD-BCE8-E744CA0B434FQ42727109-9F4248B7-669A-43EC-9061-01D58F8F9258Q43069439-0B15FD2E-E4F6-4A8B-8980-FCEDB63ECA38Q49235088-0729756C-436D-429A-AAC2-11782119ED32Q55410792-036A82D9-8832-4F20-9825-8DA8DE3280FEQ56880967-2AE5AF92-79A6-46E2-84F1-D061FF4BA8F5
P2860
Fusidic acid resistance rates and prevalence of resistance mechanisms among Staphylococcus spp. isolated in North America and Australia, 2007-2008.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Fusidic acid resistance rates ...... rica and Australia, 2007-2008.
@en
Fusidic acid resistance rates ...... rica and Australia, 2007-2008.
@nl
type
label
Fusidic acid resistance rates ...... rica and Australia, 2007-2008.
@en
Fusidic acid resistance rates ...... rica and Australia, 2007-2008.
@nl
prefLabel
Fusidic acid resistance rates ...... rica and Australia, 2007-2008.
@en
Fusidic acid resistance rates ...... rica and Australia, 2007-2008.
@nl
P2093
P2860
P356
P1476
Fusidic acid resistance rates ...... rica and Australia, 2007-2008.
@en
P2093
Amy A Watters
Jan M Bell
John D Turnidge
Ronald N Jones
P2860
P304
P356
10.1128/AAC.01390-09
P407
P577
2010-06-21T00:00:00Z